Stressor: 624
Title
Sars-CoV-2
Stressor Overview
AOPs Including This Stressor
Chemical Table
References
Port, J.R., Yinda, C.K., Avanzato, V.A. et al. Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo. Nat Microbiol 7, 213–223 (2022). https://doi.org/10.1038/s41564-021-01047-y
Goldman, E. Exaggerated risk of transmission of COVID-19 by fomites. Lancet Infect. Dis. 20, 892–893 (2020).
Centers for Disease Control and Prevention. How COVID-19 Spreads (CDC, 2021); https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/how-covid-spreads.html
Greenhalgh, T. et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet 397, 1603–1605 (2021).
Coleman, K. K. et al. Viral load of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in respiratory aerosols emitted by patients with coronavirus disease 2019 (COVID-19) while breathing, talking, and singing. Clin. Infect. Dis. https://doi.org/10.1093/cid/ciab691 (2021).
Leung, N. H. L. et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat. Med. 26, 676–680 (2020).
Laffeber, C., de Koning, K., Kanaar, R. & Lebbink, J. H. G. Experimental evidence for enhanced receptor binding by rapidly spreading SARS-CoV-2 variants. J. Mol. Biol. 433, 167058 (2021).